Clinical Trials Validating Kurve’s Technology Platform
As we advance through each clinical trial phase, we want to offer transparency and insight into our efforts. We have successfully met our endpoints in Phase IIb in 3 separate clinical trials and are currently Phase III ready.
Rigorously Tested
This is where you can find the latest list of clinical trials that Kurve has participated in, for which our next-generation technology was the device of choice.
Clinical stage
Phase 2b
We've completed our mid-stage clinical trials, and the results met their goals. Next, we'll meet with the FDA to plan the final stage of testing (Phase 3), which will begin once funding is in place.
TRIAL RESULTS
3
separate clinical trials met their endpoints (Phase 2b)
PUBLISHED RESEARCH
18
peer-reviewed publications
Kurve Therapeutics Clinical Development
NOSE-TO-BRAIN PIPELINE
program
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
Alzheimer's disease
Intranasal insulin
Parkinson's disease
Mild cognitive impairment in diabetes
ALSO STUDIED NOSE-TO-BRAIN WITH THE KURVE DEVICE
ASL
PTSD
Traumatic brain injury
Mood and anxiety disorders
Schizophrenia
Multiple sclerosis
Memory in HIV
Autism
Glioblastoma
Completed
Planned, subject to FDA meeting and funding
All programs are investigational and have not been approved by the FDA. Safety and efficacy have not been established. Stage reflects the most advanced completed study for each indication. Studies include trials run by academic and government sponsors using the Kurve device.
Rigorously Tested
We hold to the highest levels of transparency and integrity when it comes to sharing the results of our ongoing clinical trial phase. So far, we’ve met our endpoints in 3 separate clinical trials (Phase 2b) and are cleared to begin Phase 3. Here’s the latest trials we’ve participated in where our next-generation technology was the device of choice:
| Field of study | Conducted by |
|---|---|
| Alzheimer’s Disease | Johns Hopkins |
| Alzheimer’s Disease (Phase I, II and IIB) | Wake Forest |
| Alzheimer’s Disease | Shankle Neurology Clinic |
| Parkinson’s Disease | Shankle Neurology Clinic |
| Parkinson’s Disease | University of Massachusetts |
| Multi-System Atrophy | University of Massachusetts |
| Cognition in Diabetics | Harvard Medical School |
| Cognition in multiple sclerosis (MS) | Johns Hopkins |
| Traumatic Brain Injury | Department of Defense |
| PTSD | Department of Defense |
| PTSD | Mount Sinai School of Medicine |
| Neuropathic Pain | Johns Hopkins |
| Mood and Anxiety Disorders | Karolinska University (Sweden) |
| Life Extension | Karolinska University (Sweden) |
| Autism | Kurve Therapeutics |
